EFFICACY AND SAFETY OF ONE ANASTOMOSIS GASTRIC BYPASS IN SURGICAL TREATMENT OF OBESITY: SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Authors:
- Tiago Rafael OnziTOTiago Rafael Onzi
- Wilson Salgado JúniorWJWilson Salgado Júnior
- Eduardo Lemos de Souza BastosEBEduardo Lemos de Souza Bastos
- Anna Carolina Batista DantasADAnna Carolina Batista Dantas
- Lyz Bezerra SilvaLSLyz Bezerra Silva
- Alvaro Albano de Oliveira NetoANAlvaro Albano de Oliveira Neto
- Luca Schiliró TristãoLTLuca Schiliró Tristão
- Clara Lucato dos SantosCSClara Lucato dos Santos
- Wanderley Marques BernardoWBWanderley Marques Bernardo
- Matheus Pedrotti ChavezMCMatheus Pedrotti Chavez
Open Access
- 1 January 2024
- journal article
- review article
- Published by FapUNIFESP (SciELO) in ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
- Vol. 37, e1814
Abstract
BACKGROUND: One anastomosis gastric bypass (OAGB) has gained prominence in the search for better results in bariatric surgery. However, its efficacy and safety compared to Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) remain ill-defined. AIMS: To compare the efficacy and safety of OAGB relative to RYGB and SG in the treatment of obesity. METHODS: We systematically searched PubMed, EMBASE, Cochrane Library, Lilacs, and Google Scholar databases for randomized controlled trials comparing OAGB with RYGB or SG in the surgical approach to obesity. We pooled outcomes for body mass index, percentage of excess weight loss, type-2 diabetes mellitus remission, complications, and gastroesophageal reflux disease. Statistical analyses were performed with R software (version 4.2.3). RESULTS: Data on 854 patients were extracted from 11 randomized controlled trials, of which 422 (49.4%) were submitted to OAGB with mean follow-up ranging from six months to five years. The meta-analysis revealed a significantly higher percentage of excess weight loss at 1-year follow-up and a significantly lower body mass index at 5-year follow-up in OAGB patients. Conversely, rates of type-2 diabetes mellitus remission, complications, and gastroesophageal reflux disease were not significantly different between groups. The overall quality of evidence was considered very low. CONCLUSIONS: Our results corroborate the comparable efficacy of OAGB in relation to RYGB and SG in the treatment of obesity, maintaining no significant differences in type-2 diabetes mellitus remission, complications, and gastroesophageal reflux disease rates.Keywords
This publication has 53 references indexed in Scilit:
- One Anastomosis Gastric Bypass Versus Sleeve Gastrectomy for Obesity: a Systemic Review and Meta-analysisJournal of Gastrointestinal Surgery, 2023
- Evaluation of reflux following sleeve gastrectomy and one anastomosis gastric bypass: 1-year results from a randomized open-label controlled trialSurgical Endoscopy, 2020
- LSG vs MGB-OAGB—3 Year Follow-up Data: a Randomised Control TrialObesity Surgery, 2018
- The First Consensus Statement on One Anastomosis/Mini Gastric Bypass (OAGB/MGB) Using a Modified Delphi ApproachObesity Surgery, 2017
- One-Anastomosis Gastric Bypass Versus Sleeve Gastrectomy for Morbid Obesity: a Systematic Review and Meta-analysisObesity Surgery, 2017
- Bariatric Surgery and Endoluminal Procedures: IFSO Worldwide Survey 2014Obesity Surgery, 2017
- LSG vs OAGB—1 Year Follow-up Data—a Randomized Control TrialObesity Surgery, 2016
- Laparoscopic Sleeve Gastrectomy Versus Single Anastomosis (Mini-) Gastric Bypass for the Treatment of Type 2 Diabetes Mellitus: 5-Year Results of a Randomized Trial and Study of Incretin EffectObesity Surgery, 2014
- Weight Recidivism Post-Bariatric Surgery: A Systematic ReviewObesity Surgery, 2013
- Indications for Sleeve Gastrectomy as a Primary Procedure for Weight Loss in the Morbidly ObeseJournal of Gastrointestinal Surgery, 2008